Sanctuary Advisors LLC Invests $2.11 Million in The Cooper Companies, Inc. $COO

Sanctuary Advisors LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent filing with the SEC. The firm bought 29,478 shares of the medical device company’s stock, valued at approximately $2,114,000.

Several other large investors have also recently added to or reduced their stakes in COO. BlackRock Inc. acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $1,077,762,000. State Street Corp increased its holdings in Cooper Companies by 2.4% during the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after purchasing an additional 207,195 shares in the last quarter. Wellington Management Group LLP raised its position in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Generation Investment Management LLP acquired a new position in Cooper Companies in the second quarter worth $356,304,000. 24.39% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on COO. BNP Paribas Exane cut their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Robert W. Baird dropped their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Stock Performance

Cooper Companies stock opened at $72.68 on Thursday. The company has a market cap of $14.17 billion, a PE ratio of 61.59, a PEG ratio of 1.91 and a beta of 0.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company’s 50-day moving average is $72.36 and its two-hundred day moving average is $70.96.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the business posted $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.